[Testing of the resistance of human tumours in the short-term test (author's transl)].
Various human tumours have been investigated using, as previously described an in vitro method for sensitivity testing. This test provides information both on the rates of proliferation of tumours and on their resistance to cytostatic agents.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D003609:Dactinomycin / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D013936:Thymidine / Q000378:metabolism; D014228:Triaziquone / Q000627:therapeutic use; D014529:Uridine / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D003609:Dactinomycin; D004317:Doxorubicin; D014228:Triaziquone; D013936:Thymidine; D014529:Uridine; D003630:Daunorubicin
Resistenztestung von menschlichen Tumoren in Kurzzeit-Test